LifeVantage Announces Q4 and FY25 Earnings Release Date and Conference Call Details
PorAinvest
sábado, 23 de agosto de 2025, 7:56 pm ET1 min de lectura
LFVN--
The announcement comes amidst a period of significant growth and expansion for LifeVantage. The company recently announced its planned entry into the Iceland market, set to launch in September 2025, introducing a select portfolio of wellness products [2]. Additionally, LifeVantage has been expanding its international presence, with the MindBody GLP-1 System™ now available in multiple Asian and European markets [3].
Investors and stakeholders are eagerly awaiting the earnings report to gain insights into LifeVantage's financial performance, market positioning, and future growth prospects. The company's strong Q3 fiscal 2025 results, with revenue reaching $58.4 million and a net income per diluted share of $0.26, provide a positive backdrop for the upcoming announcement [4].
References:
[1] https://www.stocktitan.net/news/LFVN/
[2] https://www.stocktitan.net/news/LFVN/
[3] https://www.stocktitan.net/news/LFVN/
[4] https://www.stocktitan.net/news/LFVN/
LifeVantage Corporation will announce its Q4 and full fiscal year 2025 earnings on September 4, 2025, after market close. A conference call will be held at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) to discuss the results. A replay of the call will be available until September 18, 2025, and a webcast archive will be available for 30 days.
LifeVantage Corporation (LFVN) has scheduled its fourth quarter and full fiscal year 2025 earnings announcement for September 4, 2025, after the market close. The company will host a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time). U.S. participants can dial (877) 704-4453, while international callers should use (201) 389-0920. A replay will be available until September 18, 2025, and a live webcast will be accessible through the company's Investor Relations website, with a 30-day archive period [1].The announcement comes amidst a period of significant growth and expansion for LifeVantage. The company recently announced its planned entry into the Iceland market, set to launch in September 2025, introducing a select portfolio of wellness products [2]. Additionally, LifeVantage has been expanding its international presence, with the MindBody GLP-1 System™ now available in multiple Asian and European markets [3].
Investors and stakeholders are eagerly awaiting the earnings report to gain insights into LifeVantage's financial performance, market positioning, and future growth prospects. The company's strong Q3 fiscal 2025 results, with revenue reaching $58.4 million and a net income per diluted share of $0.26, provide a positive backdrop for the upcoming announcement [4].
References:
[1] https://www.stocktitan.net/news/LFVN/
[2] https://www.stocktitan.net/news/LFVN/
[3] https://www.stocktitan.net/news/LFVN/
[4] https://www.stocktitan.net/news/LFVN/
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios